CN115246825A - Isoxazoline derivative containing amide structure, preparation thereof and application of isoxazoline derivative as insecticide and bactericide - Google Patents

Isoxazoline derivative containing amide structure, preparation thereof and application of isoxazoline derivative as insecticide and bactericide Download PDF

Info

Publication number
CN115246825A
CN115246825A CN202110452545.6A CN202110452545A CN115246825A CN 115246825 A CN115246825 A CN 115246825A CN 202110452545 A CN202110452545 A CN 202110452545A CN 115246825 A CN115246825 A CN 115246825A
Authority
CN
China
Prior art keywords
cdcl
nmr
room temperature
under reduced
reduced pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110452545.6A
Other languages
Chinese (zh)
Inventor
汪清民
黄世盛
刘爱玲
王兹稳
李守军
李永强
李亚玲
刘玉秀
梁莉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RINGPU (TIANJIN) BIO-PHARMACY CO LTD
Nankai University
Original Assignee
RINGPU (TIANJIN) BIO-PHARMACY CO LTD
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RINGPU (TIANJIN) BIO-PHARMACY CO LTD, Nankai University filed Critical RINGPU (TIANJIN) BIO-PHARMACY CO LTD
Priority to CN202110452545.6A priority Critical patent/CN115246825A/en
Publication of CN115246825A publication Critical patent/CN115246825A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

The invention relates to an isoxazoline derivative containing an amide structure, a preparation method thereof and application thereof in the aspect of preventing and controlling pests and plant germs. The isoxazoline derivative containing the amide structure shows good activity of killing diamondback moth, oriental armyworm, spodoptera frugiperda, cotton bollworm, corn borer and mosquito larvae and activity of inhibiting plant germs.

Description

Isoxazoline derivative containing amide structure, preparation thereof and application of isoxazoline derivative as insecticide and bactericide
Technical Field
The invention relates to a novel isoxazoline derivative containing an amide structure, a preparation method thereof and application thereof in pest and plant germ prevention and control, belonging to the technical field of agricultural protection and pest prevention and control.
Background
The Food and Agricultural Organization (FAO) statistical data of the United nations show that the world food loss caused by the diseases and the insect pests accounts for about 1/3 of the total yield each year. The application of the pesticide greatly reduces the damage of farmland diseases, pests and weeds and lightens the global famine. Pests are the most important cause of crop reduction in recent decades, however, with the widespread use of insecticides, the emergence of insects resistant to various insecticides has become a serious problem worldwide. To facilitate management of pesticide resistance in agriculture and to meet the food demand of the rapidly growing population, there is an urgent need to develop green pesticides (org. Processes. Dev.2020,24, 1024-1031) that act on new targets or new sites in targets.
Since 2005 japanese daidzein chemical co-Ltd reported isoxazoline compounds as insecticides (w.o. 2005085216), they have become a focus and frontier in the field of insecticide research due to their unique insecticidal mechanism, high selectivity, no significant cross-resistance with existing insecticides, etc. as a new class of insecticides discovered in the 21 st century. Numerous research institutes have conducted extensive studies on this isoxazoline structure, and many highly active compounds have been found in extensive screening. To date, four commercial veterinary and two agricultural pesticides (formula one) (ChemMedChem 2016,11,270-276.) have been available for isoxazoline structures. Therefore, starting from the isoxazoline skeleton, the design and development of a novel high-efficiency low-toxicity isoxazoline pesticide have important significance.
Figure BDA0003039363710000011
The amide structure is an important active fragment, and is widely present in a plurality of pesticide molecules and natural products, such as flubendiamide, m-acid amide, phthalic acid formamide, o-formamido benzamide and the like, which all contain an active group with an amide structure.
Disclosure of Invention
The invention aims to provide novel isoxazoline derivatives containing an amide structure, preparation thereof and application thereof in the aspect of preventing and controlling pests and plant germs. The derivatives which are based on the conversion of cyano groups in high-activity molecules DP-9 reported by DuPont company into carboxylic acid and amide are found to have better activity for killing diamondback moth, oriental armyworm, spodoptera frugiperda, cotton bollworm, corn borer, mosquito larvae, flea, mite and tick and have activity for inhibiting plant germs for the first time by combining an intermediate derivatization method. The invention lays a foundation for creating novel, broad-spectrum and high-efficiency pesticide and has good creativity.
The isoxazoline derivative I containing the amide structure is a compound (structural formula II) shown as I-1 to I-20
Figure BDA0003039363710000021
The synthesis method of the chemical structural formulas I-1 to I-20 is as follows:
synthesis of isoxazoline derivatives I-1 to I-20 containing amide structures: according to the method shown in the equation I, 3,5-dichlorophenylboronic acid (1) and 2-bromo-3,3-trifluoropropene (2) are used as raw materials, sodium carbonate is used as alkali, bis-triphenylphosphine palladium chloride is used as a catalyst, and a coupling product 3,5-dichloro-1- (1-trifluoromethylvinyl) benzene (3) is obtained by refluxing in tetrahydrofuran and water. Taking 2-fluoro-5-formyl benzonitrile (4) as a raw material, reacting with hydroxylamine hydrochloride to generate oxime (5) in methanol and water under the catalysis of sodium carbonate, and then oxidizing and cyclizing Oxone with the synthesized 3 in water in the presence of KCl to generate 5- (5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydroisoxazol-3-yl) -2-fluorobenzonitrile (6). And then carrying out nucleophilic substitution on the potassium carbonate serving as a base and 1,2,3-triazole under the catalysis of cuprous iodide to obtain a compound DP-9. Then heating, refluxing and hydrolyzing in sodium hydroxide water solution to obtain 5- (5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydroisoxazol-3-yl) -2- (1H-1,2,4-triazol-1-yl) benzoic acid (7), and finally condensing and reacting with corresponding amine in the presence of HOBt, EDCl and triethylamine to generate I-1-I-20.
Figure BDA0003039363710000031
R in the above equation 1 ,R 2 Are respectively groups shown in structures I-1 to I-20.
The isoxazoline derivatives I-1-I-20 containing the amide structures show good killing activity on diamondback moth, armyworm, spodoptera frugiperda, cotton bollworm, corn borer, mosquito larvae, aphid, tetranychus cinnabarinus adults, fleas, ticks, demodex, scabies, earmites, culex pipiens pale subspecies and the like.
The isoxazoline derivatives I-1 to I-20 containing the amide structures show good activity of resisting plant pathogens, and can well inhibit 14 plant pathogens of cucumber wilt, peanut brown spots, apple ring lines, wheat sharp eyedrops, corn small spots, watermelon anthracnose, rice bakanae disease, tomato early blight, wheat scab, rice blast, phytophthora capsici leonian, rape sclerotium, cucumber gray mold and rice sheath blight.
Detailed Description
The following examples and biological test results are provided to further illustrate the invention and are not meant to limit the invention.
Example 1: synthesis of isoxazoline derivative I-1 containing amide structure
In the first step, 3,5-dichloro-1- (1-trifluoromethylvinyl) benzene (3) was synthesized. 3,5-dichlorophenylboronic acid (1) (57.25g, 300mmol), dichlorobis (triphenylphosphine) palladium (6.32g, 9mmol) were charged into a 2L dry three-necked flask, argon was replaced three times, and then 200mL of 3.0M aqueous potassium carbonate and 600mL of tetrahydrofuran were added via syringe, followed by 2-bromo-3,3,3-trifluoropropene (2) (37.4mL, 360mmol), and heated under reflux for 4h. After the reaction is finished, the mixture is cooled to room temperature, ice water is added, the water phase is extracted for 3 times by ethyl acetate, the combined organic phase is washed by water for 2 times, saturated sodium chloride is washed for 1 time, anhydrous sodium sulfate is dried, the mixture is concentrated under reduced pressure, and the colorless oily matter is obtained by PE column chromatography, wherein the yield is 64 percent.
Second step, synthesis of 2-fluoro-5 ((hydroxyimino) methyl) benzonitrile (5). 2-fluoro-5-formylbenzonitrile (14.91g, 100mmol) and hydroxylamine hydrochloride (10.43g, 150mmol) were dissolved in a 500mL flask containing 200mL of water and 100mL of methanol, and sodium carbonate (19.08g, 180mmol) was slowly added and stirred at room temperature overnight. Most of the methanol was removed by rotary removal under reduced pressure, and then the reaction solution was poured into 300mL of ice water to precipitate a large amount of white solid, which was filtered by suction to obtain a fluffy white powder 12.29g with a yield of 75%. 1 H NMR(400MHz,CDCl 3 )δ8.10(s,1H),7.88–7.79(m,3H),7.25(t,J=8.6Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ163.7(d,J=262.8Hz),147.3,133.4(d,J=8.7Hz),132.0,129.7(d,J=4.2Hz),117.2(d,J=20.3Hz),113.5,102.4(d,J=16.2Hz).
And step three, synthesizing 5- (5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydroisoxazol-3-yl) -2-fluorobenzonitrile (6). 3,5-dichloro-1- (1-trifluoromethylvinyl) benzene (3) (60.00g, 250mmol), 2-fluoro-5 ((hydroxyimino) methyl) benzonitrile (5) (16.4 g, 100mmol) and KCl (7.46g, 100mmol) were charged to a 1L round bottom flask, followed by 750mL of water, and finally Oxone (92.2 g, 150mmol) with stirring and stirred at room temperature for 4h. The mixture was poured into a separatory funnel, the aqueous phase was extracted 3 times with dichloromethane, the combined organic phases were washed 2 times with water, 1 time with saturated sodium chloride, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and chromatographed by PE/EA =10/1 column to give 5.40g of a white solid with a yield of 67%. 1 H NMR(400MHz,CDCl 3 )δ7.98(dd,J=8.4,5.6Hz,1H),7.89(d,J=5.6Hz,1H),7.49(s,2H),7.44(s,1H),7.32(t,J=8.4Hz,1H),4.07(d,J=17.2Hz,1H),3.70(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ164.3(d,J=265.2Hz),153.7,138.5,135.9,133.4(d,J=8.9Hz),132.1,130.1,125.4(d,J=4.1Hz),125.3,123.7(q,J=282.5Hz),117.7(d,J=20.6Hz),112.9,102.8(d,J=16.4Hz),88.0(q,J=30.7Hz),43.8.
The fourth step, the synthesis of 5- (5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydroisoxazol-3-yl) -2- (1H-1,2,4-triazol-1-yl) benzonitrile (DP-9). Reacting 5- (5- (3,5-dichlorophenyl) -5- (trifluoro-phenyl)Methyl) -4,5-dihydroisoxazol-3-yl) -2-fluorobenzonitrile (6) (33.78g, 84mmol), 1,2,4-triazole (8.12g, 117.6mmol), cuI (3.20g, 16.8mmol) and potassium carbonate (23.22g, 168mmol) were charged to a dry 250mL flask containing 160mL of ldmf, replaced with argon gas three times, and stirred with heating at 120 ℃ for 24h. The reaction mixture was cooled to room temperature, ethyl acetate was added, filtration was performed with celite, 300mL of water was added, extraction was performed with ethyl acetate 3 times, the combined organic phases were washed with water several times, washed with saturated sodium chloride 1 time, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and subjected to column chromatography with PE/EA =1/1 to obtain 34.15g of a white solid with a yield of 90%. 1 H NMR(400MHz,CDCl 3 )δ8.86(s,1H),8.16(s,1H),8.11–8.04(m,2H),7.92–7.87(m,1H),7.48(d,J=1.6Hz,2H),7.41(t,J=1.6Hz,1H),4.13(d,J=17.2Hz,1H),3.77(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ153.7,153.4,143.1,139.8,138.3,135.8,132.8,132.3,130.1,128.6,125.2,125.0,123.5(q,J=282.7Hz),115.4,106.3,88.1(q,J=30.8Hz),43.4.
The fifth step, synthesis of 5- (5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydroisoxazol-3-yl) -2- (1H-1,2,4-triazol-1-yl) benzoic acid (7). Intermediate DP-9 (18.04g, 40mmol) and sodium hydroxide (8.00g, 200mmol) were heated to reflux in a mixture of 100mL ethanol and 300mL water at 120 deg.C until the reaction was complete, and monitored by TLC plates. After the reaction is finished, cooling the mixture to room temperature, adding 500mL of water, extracting with a proper amount of ether, collecting a water phase, slowly dropwise adding 5M hydrochloric acid under vigorous stirring till the pH value is about 5, separating out a large amount of solid, and performing suction filtration to obtain 14.38g of white solid, wherein the yield is 76 percent, and the melting point is 141-144 ℃. 1 H NMR(400MHz,CDCl 3 )δ8.62(s,1H),8.16(s,1H),8.09(s,1H),7.95(d,J=8.0Hz,1H),7.58(d,J=8.0Hz,1H),7.50(d,J=1.6Hz,2H),7.43(t,J=1.6Hz),4.14(d,J=17.2Hz,1H),3.77(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ167.2,154.7,150.8,144.9,138.7,137.4,135.8,130.7,130.1,129.2,128.3,127.5,125.4,123.5(q,J=282.5Hz),88.0(q,J=30.4Hz),43.8. 19 F NMR(376MHz,DMSO-d 6 )δ-79.51(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 19 H 12 Cl 2 F 3 N 4 O 3 [M+H] + 471.0239,found,471.0233.
And step six, synthesizing I-1. To a solution of 7 (470.0mg, 1.0mmol) and aniline (0.1mL, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6 mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:1) to obtain yellow solid 346.7mg, yield 64%, melting point 242-244 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.48–8.35(m,2H),8.06(s,1H),7.95(s,1H),7.89(d,J=7.2Hz,1H),7.53–7.47(m,3H),7.44(d,J=1.2Hz,1H),7.40(d,J=7.2Hz,2H),7.28(t,2H),7.13(t,J=7.2Hz,1H),4.10(d,J=17.2Hz,1H),3.74(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ163.4,154.6,153.1,144.7,138.6,137.1,135.9,135.5,133.3,130.1,129.6,129.4,129.3,128.6,126.9,125.5,125.4,123.7(q,J=282.7Hz),120.4,88.0(q,J=30.3Hz),43.8. 19 F NMR(376MHz,CDCl 3 )δ-79.55(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 25 H 17 Cl 2 F 3 N 5 O 2 [M+H] + 546.0711,found,546.0713.
example 2: i-2 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and 2-aminopyridine (103.5mg, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16h. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain yellow solid 175.5mg, yield 33%, melting point 134-136 deg.C; 1 H NMR(400MHz,CDCl 3 )δ10.31(s,1H),8.51(s,1H),8.17(d,J=8.4Hz,1H),8.05(s,1H),8.00(dd,J=8.4,1.6Hz,1H),7.85(s,1H),7.68–7.59(m,3H),7.52(s,2H),7.46(d,J=1.6Hz,1H),6.91(t,J=6.0Hz,1H),4.07(t,J=17.2Hz,1H),3.72(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ164.6,154.6,153.0,151.2,147.3,144.0,139.0,138.7,136.0,135.8,132.2,130.1,129.6,128.8,127.9,126.0,125.5,123.7(q,J=282.6Hz),120.6,115.1,88.0(q,J=30.6Hz),43.8. 19 F NMR(376MHz,CDCl 3 )δ-79.52(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 24 H 16 Cl 2 F 3 N 6 O 2 [M+H] + 547.0664,found,547.0658.
example 3: i-3 synthesis. To a solution of 7 (470.0mg, 1.0 mmol) and 5-aminoquinoline (125.6mg, 1.10 mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5 mmol), HOBt (202.7mg, 1.5 mmol), and triethylamine (0.28mL, 2.0 mmol), and the mixture was stirred at room temperature for 16h. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying over anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain white solid 314.1mg, yield 53%, melting point 163-165 deg.C; 1 H NMR(400MHz,CDCl 3 )δ10.11(s,1H),8.73(d,J=7.2Hz,1H),8.68(dd,J=4.0,1.2Hz,1H),8.57(s,1H),8.15(dd,J=8.4,1.2Hz,1H),8.08(d,J=1.6Hz,1H),8.03–7.98(m,2H),7.70(d,J=8.4Hz,1H),7.59–7.50(m,4H),7.46–7.41(m,2H),4.17(d,J=17.2Hz,1H),3.81(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ163.9,154.7,153.0,148.5,144.1,138.7,138.4,136.5,136.0,135.8,133.8,132.6,130.0,129.5,128.8,128.0,128.0,127.3,126.1,125.4,123.7(q,J=282.6Hz),122.9,122.0,117.3,87.9(q,J=30.5Hz),43.8. 19 F NMR(376MHz,CDCl 3 )δ-79.46(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 28 H 18 Cl 2 F 3 N 6 O 2 [M+H] + 597.0820,found,597.0822.
example 4: i-4 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and 4-amino-1,1' -biphenyl (169.2mg, 1.1mmol) in methylene chloride (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:1) to obtain white pigment621.1mg of a colored solid, 60% of yield and 194-196 ℃ of melting point; 1 H NMR(400MHz,CDCl 3 )δ8.49(s,1H),8.36(s,1H),8.14(s,1H),8.03(d,J=1.6Hz,1H),7.94(dd,J=8.4,1.6Hz,1H),7.56–7.49(m,9H),7.45–7.40(m,3H),7.34(dd,J=7.2,1.6Hz,1H),4.13(d,J=17.2Hz,1H),3.76(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ163.5,154.7,153.0,144.6,140.2,138.5,138.3,136.4,135.9,135.6,133.1,130.1,129.5,129.2,129.0,128.4,127.8,127.5,127.0,126.6,125.4,123.7(q,J=282.5Hz),120.7,88.0(q,J=30.7Hz),43.7. 19 F NMR(376MHz,CDCl 3 )δ-79.56(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 31 H 21 Cl 2 F 3 N 5 O 2 [M+H] + 622.1024,found,622.1015.
example 5: i-5 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and 4-aminodiphenyl ether (185.2mg, 1.1mmol) in methylene chloride (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:1) to obtain white solid 409.5mg, yield 64%, melting point 112-115 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.48(s,1H),8.23(s,1H),8.13(s,1H),8.01(d,J=2.0Hz,1H),7.94(dd,J=8.4,2.0Hz,1H),7.55(d,J=8.4Hz,1H),7.50(d,J=1.6Hz,2H),7.44(t,J=1.6Hz,1H),7.39(dt,J=9.2,2.4Hz,2H),7.36–7.30(m,2H),7.10(tt,J=7.2,0.8Hz,1H),7.01–6.97(m,2H),6.97–6.93(m,2H),4.13(d,J=17.2Hz,1H),3.77(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ163.5,157.2,154.7,154.5,152.9,144.5,138.5,135.8,135.5,132.9,132.5,130.1,129.9,129.4,129.0,128.3,126.4,125.4,123.7(q,J=283.1Hz),123.5,122.1,119.5,118.8,87.9(q,J=30.4Hz),43.7. 19 F NMR(376MHz,CDCl 3 )δ-79.55(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 31 H 21 Cl 2 F 3 N 5 O 3 [M+H] + 638.0974,found,638.0966.
example 6: i-6 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and N-methylaniline (117.9mg, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain 332.8mg as brown solid with yield of 60% and melting point of 92-95 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.25(s,1H),8.11(s,1H),7.74–7.68(m,2H),7.49(d,J=1.6Hz,2H),7.45(t,J=2.0Hz,1H),7.34(d,J=8.4Hz,1H),7.11–7.06(m,3H),6.63(dd,J=6.4,3.2Hz,2H),4.03(d,J=17.2Hz,1H),3.66(d,J=17.2Hz,1H),3.40(s,3H). 13 C NMR(100MHz,CDCl 3 )δ167.0,154.6,152.8,143.1,142.1,138.8,135.9,135.2,131.8,130.1,129.3,128.6,128.5,127.9,127.4,126.2,125.4,124.0,123.7(q,J=282.7Hz),87.7(q,J=30.6Hz),43.9,37.4. 19 F NMR(376MHz,CDCl 3 )δ-79.51(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 26 H 19 Cl 2 F 3 N 5 O 2 [M+H] + 560.0868,found,560.0863.
example 7: i-7 synthesis. EDCI hydrochloride (287.6 mg,1.5 mmol), HOBt (202.7 mg,1.5 mmol), and triethylamine (0.28mL, 2.0 mmol) were added to a solution of 7 (470.0mg, 1.0mmol) and benzylamine (117.9mg, 1.1mmol) in dichloromethane (5 mL) at room temperature, and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:1) to obtain yellow solid 457.9mg, with yield 82%, melting point 68-71 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.38(s,1H),7.94(s,1H),7.87(t,J=9.4Hz,1H),7.54–7.47(m,3H),7.43(t,J=2.0Hz,1H),7.33–7.26(m,3H),7.15(d,J=6.8Hz,2H),6.65(s,1H),4.42(d,J=5.6Hz,2H),4.11(d,J=17.2Hz,1H),3.74(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ165.4,154.7,152.8,144.5,138.6,137.0,135.8,135.7,133.0,130.0,129.2,129.0,128.9,128.1,128.0,128.0,126.6,125.4,123.7(q,J=282.8Hz),87.9(q,J=30.4Hz),44.5,43.8. 19 F NMR(376MHz,CDCl 3 )δ-79.54(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 26 H 19 Cl 2 F 3 N 5 O 2 [M+H] + 560.0868,found,560.0869.
example 8: i-8 synthesis. To a solution of 7 (470.0mg, 1.0 mmol) and 2-aminomethylpyridine (119.0mg, 1.10 mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5 mmol), HOBt (202.7mg, 1.5 mmol), and triethylamine (0.28mL, 2.0 mmol), and the mixture was stirred at room temperature for 16h. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (dichloromethane) = V (methanol) = 30) to obtain white solid 460.4mg, yield 82%, melting point 107-110 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.44–8.27(m,3H),7.93(s,1H),7.88(s,1H),7.83(d,J=8.0Hz,1H),7.52(d,J=7.6Hz,1H),7.50–7.45(m,3H),7.41(s,2H),7.21(t,J=4.4Hz,1H),4.41(d,J=5.2Hz,2H),4.10(d,J=17.2Hz,1H),3.75(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ165.8,154.8,152.7,149.2,149.0,144.3,138.5,136.0,135.8,135.7,133.2,132.7,130.0,129.3,128.9,127.9,126.3,125.3,123.8,123.7(q,J=282.3Hz),87.9(q,J=30.4Hz),43.7,41.7. 19 F NMR(376MHz,CDCl 3 )δ-79.56(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 25 H 18 Cl 2 F 3 N 6 O 2 [M+H] + 561.0820,found,561.0818.
example 9: i-9 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and methylamine hydrochloride (74.3mg, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.42mL, 3.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain white solid 370.5mg, yield 77%, melting point 189-190 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.47(s,1H),8.11(s,1H),7.92–7.87(m,2H),7.59–7.56(m,1H),7.50(d,J=1.2Hz,2H),7.45(t,J=1.6Hz,1H),6.22(s,1H),4.12(d,J=17.2Hz,1H),3.76(d,J=17.2Hz,1H),2.85(d,J=4.8Hz,3H). 13 C NMR(100MHz,CDCl 3 )δ166.3,154.8,152.8,144.4,138.6,135.8,135.7,132.7,130.0,129.1,128.7,127.8,126.3,125.3,123.7(q,J=282.7Hz),87.8(q,J=30.5Hz),43.7,26.9. 19 FNMR(376MHz,CDCl 3 )δ-79.54(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 20 H 15 Cl 2 F 3 N 5 O 2 [M+H] + 484.0555,found,484.0552.
example 10: i-10 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and trifluoroethylamine hydrochloride (149.1mg, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.42mL, 3.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain white solid 453.9mg, with yield 82% and melting point 158-160 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.39(s,1H),8.08(s,1H),7.93(s,2H),7.53(d,J=8.8Hz,1H),7.49(s,2H),7.44(t,J=1.6Hz,1H),7.00(s,1H),4.12(d,J=17.2Hz,1H),3.99–3.89(m,2H),3.76(d,J=17.2Hz,1H). 13 CNMR(100MHz,CDCl 3 )δ165.9,154.6,152.9,144.4,138.5,135.8,135.6,131.9,130.1,129.8,129.2,128.2,126.6,125.3,123.8(q,J=276.8Hz),123.7(q,J=282.6Hz),88.0(q,J=30.4Hz),43.7,41.2(q,J=34.7Hz). 19 F NMR(376MHz,CDCl 3 )δ-71.99(s),-79.52(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 21 H 14 Cl 2 F 6 N 5 O 2 [M+H] + 552.0429,found,552.0419.
example 11: synthesis of I-11. To a solution of 7 (470.0mg, 1.0mmol) and cyclopropylamine (62.8mg, 1.1mmol) in methylene chloride (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile matter under reduced pressureExtracting the fermentation product with dichloromethane, washing the organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain white solid 416.6mg, with yield of 82% and melting point of 153-155 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.43(s,1H),8.11(s,1H),7.90(dd,J=8.4,2.0Hz,1H),7.87(d,J=2.0Hz,1H),7.55(d,J=8.4Hz,1H),7.50(d,J=1.6Hz,2H),7.44(t,J=1.6Hz,1H),6.19(s,1H),4.12(d,J=17.2Hz,1H),3.75(d,J=17.2Hz,1H),2.78–2.69(m,2H),0.78(q,J=6.4Hz,2H),0.42(q,J=5.2Hz,2H). 13 CNMR(100MHz,CDCl 3 )δ166.9,154.7,152.9,144.6,138.6,135.9,135.7,133.2,130.1,129.3,129.1,128.1,126.7,125.2,123.7(q,J=280.3Hz)87.9(q,J=30.5Hz),43.8,23.3,6.7. 19 F NMR(376MHz,CDCl 3 )δ-79.55(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 22 H 17 Cl 2 F 3 N 5 O 2 [M+H] + 510.0711,found,570.0712.
example 12: i-12 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and propargylamine (60.6mg, 1.1mmol) in methylene chloride (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain pale yellow solid 364.0mg, yield 72%, melting point 93-96 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.43(s,1H),8.09(s,1H),7.92–7.86(m,2H),7.55(d,J=8.8Hz,1H),7.49(d,J=1.2Hz,2H),7.43(t,J=1.6Hz,1H),6.74(s,1H),4.12(d,J=17.2Hz,1H),4.06(dd,J=4.8,2.4Hz,2H),3.75(d,J=17.2Hz,1H),2.25(t,J=2.4Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ165.2,154.6,153.1,144.6,138.6,135.9,135.8,132.3,130.1,129.6,129.1,128.2,126.6,125.4,123.7(q,J=282.6Hz),88.0(q,J=30.5Hz),78.3,72.6,43.8,30.0. 19 F NMR(376MHz,CDCl 3 )δ-79.54(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 22 H 15 Cl 2 F 3 N 5 O 2 [M+H] + 508.0555,found,508.0550.
example 13: i-13 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and allylamine hydrochloride (102.9mg, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain pale yellow solid 474.6mg, yield 93%, melting point 140-143 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.44(s,1H),8.09(s,1H),7.89(dd,J=7.2,2.0Hz,2H),7.56(dd,J=9.2,2.0Hz,2H),7.49(d,J=1.6Hz,2H),7.44(t,J=2.0Hz,1H),6.30(t,J=5.6Hz,1H),5.73(ddt,J=16.4,10.4,5.6Hz,1H),5.12(tq,J=9.6,1.6Hz,2H),4.12(d,J=17.2Hz,1H),3.90(tt,J=5.6,1.2Hz,2H),3.75(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ165.5,154.7,152.8,144.4,138.6,135.8,135.6,133.0,132.8,130.0,129.2,128.8,127.9,126.4,125.3,123.7(q,J=282.7Hz),117.5,87.8(q,J=30.5Hz),43.7,42.62. 19 F NMR(376MHz,CDCl 3 )δ-79.54(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 22 H 17 Cl 2 F 3 N 5 O 2 [M+H] + 510.0711,found,510.0710.
example 14: i-14 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and 2-methoxyethylamine (82.6mg, 1.1mmol) in methylene chloride (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (dichloromethane) = V (methanol) = 1:1) to obtain white solid 389.0mg, with yield of 74% and melting point of 85-87 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.44(s,1H),8.08(s,1H),7.88(d,J=7.6Hz,2H),7.57(d,J=8.8Hz,1H),7.49(d,J=1.2Hz,2H),7.43(t,J=1.6Hz,1H),6.47(s,1H),4.11(d,J=17.2Hz,1H),3.75(d,J=17.2Hz,1H),3.46(q,J=5.2Hz,2H),3.37(t,J=5.2Hz,2H),3.28(s,3H). 13 C NMR(100MHz,CDCl 3 )δ165.7,154.7,152.8,144.3,138.6,135.7,135.6,132.7,130.0,129.1,128.7,127.8,126.3,125.3,123.7(q,J=282.7Hz),87.8(q,J=30.5Hz),70.5,58.7,43.7,39.9. 19 F NMR(376MHz,CDCl 3 )δ-79.54(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 22 H 19 Cl 2 F 3 N 5 O 3 [M+H] + 528.0817,found,528.0811.
example 15: i-15 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and glycine methyl ester hydrochloride (138.1mg, 1.1mmol) in methylene chloride (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.42mL, 3.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain light yellow solid 432.0mg, yield 80%, melting point 186-189 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.49(s,1H),8.11(s,1H),7.96–7.92(m,2H),7.61(dd,J=8.8,0.8Hz,1H),7.50(d,J=1.6Hz,2H),7.44(t,J=1.6Hz,1H),6.70(t,J=4.4Hz,1H),4.13(d,J=17.2Hz,1H),4.09(d,J=5.2Hz,2H),3.76(s,3H),3.75(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ169.6,165.8,154.7,153.0,144.6,138.6,135.9,135.8,131.8,130.1,129.6,128.9,128.1,126.6,125.4,123.7(q,J=282.7Hz),87.9(q,J=30.5Hz),52.7,43.8,41.8. 19 F NMR(376MHz,CDCl 3 )δ-79.53(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 22 H 17 Cl 2 F 3 N 5 O 4 [M+H] + 542.0610,found,542.0601.
example 16: i-16 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and 2-amino-N-methylacetamide (96.9mg, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile matter under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, and concentrating under reduced pressurePerforming column chromatography (V (dichloromethane) = 40) to obtain 433.2mg white solid, the yield is 80%, and the melting point is 115-118 ℃; 1 H NMR(400MHz,CDCl 3 )δ8.49(s,1H),7.97(s,1H),7.84–7.79(m,2H),7.70(t,J=5.6Hz,1H),7.53(d,J=8.4Hz,1H),7.45(d,J=1.6Hz,2H),7.39(t,J=1.6Hz,1H),6.89(q,J=4.8Hz,1H),4.10(d,J=17.2Hz,1H),3.85(d,J=5.6Hz,2H),3.76(d,J=17.2Hz,1H),2.71(d,J=4.4Hz,3H). 13 C NMR(100MHz,CDCl 3 )δ169.0,166.5,154.8,152.6,144.1,138.5,135.8,135.7,131.6,130.0,129.4,128.6,127.6,125.5,125.3,123.7(q,J=282.6Hz),87.9(q,J=30.4Hz),43.6,43.5,26.2. 19 F NMR(376MHz,CDCl 3 )δ-79.56(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 22 H 18 Cl 2 F 3 N 6 O 3 [M+H] + 541.0770,found,541.0762.
example 17: i-17 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and 2-amino-N- (2,2,2-trifluoroethyl) acetamide hydrochloride (211.8mg, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), triethylamine (0.42mL, 3.0mmol), and the mixture was stirred at room temperature for 16h. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain white solid 476.8mg, yield 78%, melting point 101-104 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.49(s,1H),8.07(s,1H),7.93–7.89(m,2H),7.58(d,J=8.0Hz,1H),7.49(d,J=1.2Hz,2H),7.44(t,J=2.0Hz,1H),7.13(s,1H),7.06(s,1H),4.12(d,J=17.0Hz,1H),4.07(d,J=5.6Hz,2H),3.99–3.89(m,2H),3.75(d,J=17.2Hz,1H). 13 C NMR(100MHz,CDCl 3 )δ168.8,166.5,154.5,153.1,144.1,138.6,135.9,135.8,131.6,130.1,129.8,129.1,127.8,125.9,125.4,123.9(q,J=276.8Hz),123.7(q,J=282.7Hz),88.0(d,J=30.6Hz),43.8,43.7,40.85(d,J=35.0Hz). 19 F NMR(376MHz,CDCl 3 )δ-72.21(s),-79.62(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 23 H 17 Cl 2 F 6 N 6 O 3 [M+H] + 604.0643,found,604.0634.
example 18: i-18 synthesis. To a solution of 7 (470.0mg, 1.0 mmol) and diethylamine (80.4mg, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6 mg,1.5 mmol), HOBt (202.7mg, 1.5 mmol), and triethylamine (0.28mL, 2.0 mmol), and the mixture was stirred at room temperature for 16h. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain white solid 418.9mg, yield 80%, melting point 65-67 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.55(s,1H),8.09(s,1H),7.84(dd,J=8.4,1.2Hz,1H),7.72(d,J=8.4Hz,1H),7.68(d,J=1.6Hz,1H),7.50(d,J=1.6Hz,2H),7.43(t,J=1.6Hz,1H),4.10(dd,J=17.2,6.8Hz,1H),3.73(dd,J=17.2,6.8Hz,1H),3.59(t,J=6.4Hz,1H),3.33(t,J=6.4Hz,1H),2.97(dd,J=18.4,6.8Hz,2H),1.13(t,J=7.2Hz,3H),0.83(t,J=7.2Hz,3H). 13 C NMR(100MHz,CDCl 3 )δ166.7,154.7,152.9,144.0,138.7,135.8,135.0,132.2,123.0,128.5,128.3,126.2,125.3,125.2,123.7(q,J=282.8Hz),87.7(q,J=30.5Hz),43.8,43.1,39.4,13.6,12.3. 19 F NMR(375MHz,CDCl 3 )δ-79.44(s),-79.60(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 23 H 21 Cl 2 F 3 N 5 O 2 [M+H] + 526.1024,found,526.1019.
example 19: i-19 synthesis. EDCI hydrochloride (287.6 mg,1.5 mmol), HOBt (202.7 mg,1.5 mmol) and triethylamine (0.28mL, 2.0 mmol) were added to a solution of 7 (470.0mg, 1.0mmol) and morpholine (95.8mg, 1.1mmol) in dichloromethane (5 mL) at room temperature, and the mixture was stirred at room temperature for 16 hours. Removing volatile under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (petroleum ether) = V (ethyl acetate) = 1:2) to obtain white solid 345.6mg, yield 64%, melting point 79-81 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.52(s,1H),8.13(s,1H),7.88(dd,J=8.4,2.0Hz,1H),7.71(d,J=2.0Hz,1H),7.68(d,J=8.4Hz,1H),7.50(s,2H),7.44(t,J=2.0Hz,1H),4.11(dd,J=17.2,4.8Hz,1H),3.84–3.77(m,1H),3.77–3.68(m,2H),3.63–3.47(m,3H),3.20–3.10(m,2H),3.00–2.92(m,1H). 13 C NMR(100MHz,CDCl 3 )δ166.1,154.5,153.2,143.5,138.7,138.6,135.9,135.3,131.2,130.1,128.8,128.8,126.7,127.7,125.4,124.9,123.7(q,J=282.5Hz),87.9(q,J=30.4Hz),66.4,66.2,47.3,43.8,42.3. 19 F NMR(375MHz,CDCl 3 )δ-79.40(s),-79.57(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 23 H 19 Cl 2 F 3 N 5 O 3 [M+H] + 540.0817,found,540.0814.
example 20: i-20 synthesis. To a solution of 7 (470.0mg, 1.0mmol) and N-methylpiperazine (110.2mg, 1.1mmol) in dichloromethane (5 mL) at room temperature were added EDCI hydrochloride (287.6mg, 1.5mmol), HOBt (202.7mg, 1.5mmol), and triethylamine (0.28mL, 2.0mmol), and the mixture was stirred at room temperature for 16 hours. Removing volatile matter under reduced pressure, extracting with dichloromethane, washing organic phase with saturated sodium carbonate aqueous solution, drying with anhydrous sodium sulfate, concentrating under reduced pressure, and performing column chromatography (V (dichloromethane) = V (methanol) = 40) to obtain pale yellow solid 495.2mg, yield 90%, melting point 106-108 deg.C; 1 H NMR(400MHz,CDCl 3 )δ8.50(s,1H),8.09(s,1H),7.86(dt,J=8.4,2.0Hz,1H),7.71–7.66(m,2H),7.48(s,2H),7.42(t,J=2.0Hz,1H),4.10(dd,J=17.2,5.6Hz,1H),3.85–3.76(m,1H),3.72(dd,J=17.2,4.0Hz,1H),3.62–3.51(m,1H),3.17–3.06(m,1H),2.99–2.89(m,1H),2.48–2.40(m,1H),2.25–2.15(m,5H),1.75–1.64(m,1H). 13 C NMR(100MHz,CDCl 3 )δ165.8,154.6,152.9143.5,138.7,138.6,135.7,135.1,131.3,123.0,129.9,128.7,128.6,126.6,126.6,125.3,124.8,123.7(q,J=282.8Hz),87.7(q,J=30.6Hz),54.4,54.2,46.8,45.9,43.8,41.8. 19 F NMR(376MHz,CDCl 3 )δ-79.39(s),-79.58(s).Mass Spectrometry:HRMS-ESI(m/z):calcd for C 24 H 22 Cl 2 F 3 N 6 O 2 [M+H] + 553.1133,found,553.1133.
example 21: the isoxazoline amide compounds I-1 to I-20 are used for measuring the insecticidal activity of diamondback moth (Plutella xylostella), armyworm (Mythimna separata), cotton bollworm (Helicoverpa armigera), corn borer (0 strinia nubilalis), culex pipiens pallidus (Culex pipiens pallens), aphid (Aphis lambanus Kaltenbach) and the acaricidal activity of Tetranyhus cinnabarinus (Tetranyhus cinnabarinus), and the measuring programs are as follows:
testing the activity of armyworm: armyworm (Mythimna separata Walker), a normal population raised indoors. The test method comprises the following steps: the leaf soaking method comprises soaking folium Maydis in medicinal liquid prepared from acetone, inoculating 10-head larvae of 3 years old after the medicinal liquid is dried, mainly performing stomach poisoning and contact killing, and observing feeding phenomenon of the larvae. Mortality was checked for 72 h. Each compound was repeated 3 times.
Mortality (%) = (number of dead insects applied/total number of insects applied) × 100
Corrected mortality (%) = [ (drug application mortality-blank mortality)/(1-blank mortality) ] × 100
Cotton bollworm activity test: helicoverpa armigera (Helicoverpa armigera), a normal population raised indoors. The test method comprises the following steps: leaf soaking method. Soaking corn leaf in liquid medicine prepared from acetone, inoculating 10 larvae of 3 years old after the liquid medicine is dried, mainly performing stomach toxicity and contact killing, and observing feeding phenomenon of the larvae. Mortality was checked after 72 h. Each compound was repeated 3 times.
Activity test of corn borer: corn borer (0 strinia nubilalis Hubner), a normal population raised indoors. The test method comprises the following steps: leaf soaking method. Soaking corn leaf in liquid medicine prepared from acetone, inoculating 10 larvae of 3 years old after the liquid medicine is dried, mainly performing stomach toxicity and contact killing, and observing feeding phenomenon of the larvae. Mortality was checked after 72 hours. Each compound was repeated 3 times.
Activity test of plutella xylostella: diamondback moth (Plutella xylostella), a normal population raised indoors. The test method comprises the following steps: leaf soaking. Dipping the cabbage leaves into the liquid medicine with proper concentration by using straight-head ophthalmic forceps for 3-5 seconds, and throwing off residual liquid. One sheet at a time, 3 sheets per sample, were placed on the treatment paper in order of sample label. After the liquid medicine is dried, the liquid medicine is put into a straight pipe with the length of 10cm and provided with a mark, 10 second-instar larvae are inoculated, and the pipe openings of the second-instar larvae are covered by gauze. The experimental treatments were placed in a standard room and the results were checked after 4 days. Each compound was repeated 3 times.
Activity test of culex larvae: culex pipiens pallens (culex pallens), a normal population raised indoors. 10 larvae of culex 3 instars were selected and placed in a beaker of 100mL of the prepared desired concentration. Treatments were placed in a standard treatment room and mortality was checked after 72 h. An aqueous solution containing 1mL of test solvent was used as a blank. Each compound was repeated 3 times.
Aphid activity test: aphid (Aphis laburnii Kaltenbach), a normal population raised by laboratory broad bean leaves. Weighing the medicines, adding 1ml of DMMF to dissolve, adding two drops of Tween-20 emulsifier, adding a certain amount of distilled water, and stirring uniformly to prepare the liquid medicine with the required concentration. Soaking the leaves of broad beans with aphids (about 60) in the medicament for 5 seconds, taking out, slightly drying, sucking the redundant medicament with filter paper, inserting the branches of the broad beans into water-absorbing sponge, covering the branches with glass covers, sealing with gauze, checking the result after 96 hours, and repeating each compound for 3 times. The control was prepared by adding the emulsifier and solvent to distilled water and stirring the mixture uniformly.
Testing the activity of tetranychus cinnabarinus adults: when Tetranychus cinnabarinus (Tetranychus cinnabarinus) for experiments grows to two true leaves of dwarf beans, plants with regular growth vigor, 4-5 square centimeters of leaf area and about 10 centimeters of plant height are selected for grafting, and the quantity of each plant is controlled to be about 60-100. And (5) after inoculating the insects for 2h, carrying out medicament treatment. The medicament treatment adopts a plant dipping method, and the dipping time is 5 seconds. After the plants are taken out of the liquid medicine, the plants are shaken slightly to throw off the redundant liquid medicine, then the plants are moved into a water culture tank and placed at room temperature. The results were examined under binoculars 24h after treatment. Each compound was repeated 3 times.
TABLE 1 Activity test results of Compounds I-1 to I-20 against armyworm, diamondback moth, heliothis armigera and corn borer
Figure BDA0003039363710000121
a Activities at 200mg/L. b Activities at 100mg/L. c Activities at 10mg/L d Activities at 1mg/L, e Activities at 0.1mg/L.
TABLE 2 Activity test results of Compounds I-1 to I-20 against mosquito larvae, helicoverpa armigera, corn borer
Figure BDA0003039363710000131
a Activities at 200mg/L. b Activities at 100mg/L. c Activities at 5mg/L, d Activities at 2mg/L. e Activities at 1mg/L. f Activities at 0.5mg/L, g Activities at 0.25mg/L. h Activities at 0.1mg/L. i Activities at0.05 mg/L, j Activities at0.025 mg/L.
The commercial varieties Fluralaner and DP-9 are used as a control to test the insecticidal activity of diamondback moth, armyworm, spodoptera frugiperda, cotton bollworm, corn borer, culex pipiens L.sp.pipiens, aphid and the mite-killing activity of Tetranychus cinnabarinus. The test result shows that most of the derivatives show higher activity. The compounds I-3, I-7, I-9-I-12, I-16, I-18 and I-20 have 100 percent of lethality to armyworms at the concentration of 200 mg/L; the compounds I-11 and I-16 have a lethality rate of more than 80 percent to diamondback moth at a concentration of 1 mg/L; the compounds I-7 and I-18 have 100 percent of lethality to culex pipiens pallens larvae at the concentration of 0.1 mg/L; most compounds show certain activity for killing cotton bollworms and corn borers.
Example 22: antibacterial activity test, the determination procedure is as follows:
ex vivo sterilization test, cell growth rate assay (plate method):
dissolving a certain amount of medicament in a proper amount of acetone, then diluting the solution to a required concentration by using an emulsifier aqueous solution containing 200 mug/mL, sucking 1mL of liquid medicine respectively, injecting the liquid medicine into a culture dish, adding 9mL of culture medium respectively, shaking the liquid medicine uniformly to prepare a medicine-containing plate with 50 mug/mL, and taking the plate added with 1mL of sterilized water as a blank control. Cutting the plate with a punch with diameter of 4mm along the outer edge of the hypha, and transferring to a medicated plate. Each treatment was repeated three times. The culture dish is placed in a constant temperature incubator at 24 +/-1 ℃ for culture. And after 48 hours, investigating the expansion diameter of each treated bacterium disc, calculating an average value, and comparing with a blank control to calculate the relative bacteriostasis rate.
Figure BDA0003039363710000132
TABLE 3 Activity test results of Compounds I-1 to I-20 on plant pathogens
Figure BDA0003039363710000141
The activity test of 14 plant fungi is carried out by taking broad-spectrum bactericides carbendazim, chlorothalonil, fluralaner and DP-9 as controls, and the test result shows that part of compounds show broad-spectrum inhibitory activity to 14 tested bacteria under the condition that the test concentration is 50 mg/L. Wherein, the inhibition rate of the derivatives I-10, I-11 and I-18-I-20 on the peanut brown spot pathogen is superior to DP-9 (51%), fluralaner (30%), chlorothalonil (44%) and pyrimethamine (18%), and the inhibition rate of most derivatives on the wheat sheath blight pathogen reaches more than 90%. I-17 has higher bactericidal activity to tomato early blight bacteria than or equal to that of a control sample; the inhibition rate of I-7, I-11 and I-20 on the ring rot of apple reaches more than 90 percent; the inhibition rate of I-3 to phytophthora capsici reaches 79%.

Claims (4)

1. The isoxazoline derivative I containing the amide structure is a compound shown in the following structure, and specifically is a compound shown in I-1 to I-20:
Figure FDA0003039363700000011
2. the method for producing isoxazoline derivatives I-1 to I-20 having an amide structure according to claim 1, which comprises: firstly, using 3,5-dichlorophenylboronic acid (1) and 2-bromo-3,3-trifluoropropene (2) as raw materials, sodium carbonate as alkali, bis-triphenylphosphine palladium chloride as a catalyst, and refluxing in tetrahydrofuran and water to obtain a coupling product 3,5-dichloro-1- (1-trifluoromethylvinyl) benzene (3); taking 2-fluoro-5-formyl benzonitrile (4) as a raw material, reacting with hydroxylamine hydrochloride to generate oxime (5) in methanol and water under the catalysis of sodium carbonate, and then oxidizing and cyclizing with Oxone in water and KCl to generate 5- (5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydroisoxazol-3-yl) -2-fluorobenzonitrile (6) in water with the synthesized 3; then carrying out nucleophilic substitution on potassium carbonate serving as alkali and 1,2,3-triazole under the catalysis of cuprous iodide to obtain a compound DP-9; then heating, refluxing and hydrolyzing in sodium hydroxide aqueous solution to obtain 5- (5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydroisoxazol-3-yl) -2- (1H-1,2,4-triazol-1-yl) benzoic acid (7), and finally condensing and reacting with corresponding amine in the presence of HOBt, EDCl and triethylamine to generate I-1-I-20
Figure FDA0003039363700000021
R 1 And R 2 Respectively represent groups shown in structures I-1 to I-20.
3. The application of the isoxazoline derivative I-1 to I-20 containing the amide structure in the claim 1 in pest control is characterized in that the pests are diamondback moth, armyworm, spodoptera frugiperda, cotton bollworm, corn borer, mosquito larva, aphid, tetranychus cinnabarinus adult mite, flea, tick, demodex, scabies mite and earmite.
4. The application of the isoxazoline derivatives I-1 to I-20 containing the amide structures in the claim 1 in preventing and treating plant pathogens, which is characterized in that the plant pathogens are cucumber fusarium wilt, peanut brown spots, apple ring rot, wheat sharp eyespot, corn small spot, watermelon anthracnose, rice bakanae disease, tomato early blight, wheat gibberella, rice blast, phytophthora capsici, sclerotium napellum, cucumber gray mold or rice sheath blight.
CN202110452545.6A 2021-04-26 2021-04-26 Isoxazoline derivative containing amide structure, preparation thereof and application of isoxazoline derivative as insecticide and bactericide Pending CN115246825A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110452545.6A CN115246825A (en) 2021-04-26 2021-04-26 Isoxazoline derivative containing amide structure, preparation thereof and application of isoxazoline derivative as insecticide and bactericide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110452545.6A CN115246825A (en) 2021-04-26 2021-04-26 Isoxazoline derivative containing amide structure, preparation thereof and application of isoxazoline derivative as insecticide and bactericide

Publications (1)

Publication Number Publication Date
CN115246825A true CN115246825A (en) 2022-10-28

Family

ID=83696063

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110452545.6A Pending CN115246825A (en) 2021-04-26 2021-04-26 Isoxazoline derivative containing amide structure, preparation thereof and application of isoxazoline derivative as insecticide and bactericide

Country Status (1)

Country Link
CN (1) CN115246825A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007016017A (en) * 2005-06-06 2007-01-25 Nissan Chem Ind Ltd Substituted isoxazoline compound and pest control agent
CN101331127A (en) * 2005-12-16 2008-12-24 杜邦公司 5-aryl isoxazolines for controlling invertebrate pests

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007016017A (en) * 2005-06-06 2007-01-25 Nissan Chem Ind Ltd Substituted isoxazoline compound and pest control agent
CN101331127A (en) * 2005-12-16 2008-12-24 杜邦公司 5-aryl isoxazolines for controlling invertebrate pests

Similar Documents

Publication Publication Date Title
CN110092776B (en) Pyrazole oxime ester compound containing pyridine-difluoride pyrazole structure and preparation method and application thereof
JP6710273B2 (en) Cyclic amine compound and pest control agent
JP2006290883A (en) Substituted heterocycle carboxylic anilide derivative, its intermediate and chemical for agriculture and horticulture and method for using the same
CN110128409B (en) Preparation and application of difluoromethylpyrazole oxime derivative containing pyridine bipyrazole structure
WO2006022225A1 (en) Optically active phthalamide derivative, agricultural or horticultural insecticide, and method of using the same
WO2007108483A1 (en) N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
WO2007125984A1 (en) Isoxazoline derivative, pest-controlling agent, and use of the pest-controlling agent
EA019243B1 (en) Insecticidal compounds
WO2014187298A1 (en) N-pyridine amide compound, preparation method therefor, and application thereof
WO2014187297A1 (en) N-pyridine(hetero)aromatic amide compound and preparation method and use thereof
EP3889137A1 (en) Cyclic amine compound and pest control agent
CN110407831B (en) Preparation and application of pyrazole oxime ester derivative containing N- (3-chloropyridine-2-yl) pyrazole structure
CN106243039B (en) Preparation method and application of pyrazole oxime compound containing 1-methyl-3-ethyl-4-chloro-5-formylpyrazole structure
JP2008222709A (en) Pest control agent composition and use of the same
CN110407813B (en) Pyrazole oxime compound containing 1- (3-chloropyridine-2-yl) pyrazole structure and preparation method and application thereof
KR20220015388A (en) Pyridinium salts and pest control agents
KR20220016459A (en) Pyridinium salts and pest control agents
WO2017069154A1 (en) Amide compound and pest control agent
CN115246825A (en) Isoxazoline derivative containing amide structure, preparation thereof and application of isoxazoline derivative as insecticide and bactericide
CN115246795B (en) Isoxazoline compound containing ether structure at 4-phenyl para-position, preparation method thereof and application thereof as insecticidal and bactericidal agent
JP2004269515A (en) Substituted heterocyclic amide derivative, its intermediate, agricultural and horticultural agent and method for using them
US7994339B2 (en) Phthalamide derivative, agricultural or horticultural pesticide, and use of the pesticide
CN109232534B (en) Heterocyclic diarylamine-containing pyrazole formamide compound and preparation method and application thereof
CN115246826B (en) Quaternary ammonium salt isoxazoline compound, its preparation and application as insecticidal and bactericidal agent
CN111978306A (en) Furanol pyrazole formamide derivative and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination